Prof. Sabine Kasimir-Bauer
The most important advancement in cancer research that must happen in the next five years …
I think that we all have to be “more translational,” use the scientific resources we have, build up scientific networks, include clinicians and also pharmaceutical companies to move ideas forward more quickly.
How societies should change over the next 10 years to help control and prevent cancer …
I think that we have to start early, especially with prevention programs. Kids at school should learn about the dangers of smoking and should be educated about nutrition – also adiposity, which might lead to a variety of other diseases. Of course, this will not necessarily protect from cancer, but may protect from other diseases that finally could lead to cancer.
I would recommend to young scientists …
Not to give up. If you are fond of science, stick to it. Of course, there are frustrating moments when your paper or grant has been rejected but believe in your ideas, be open and build up your network. Finally, you will be successful.
I want to be remembered …
As a deep hearted, honest scientist who is doing research to improve the prognosis of our breast and ovarian cancer patients and who is always inspiring and supporting young scientists.
Dr. Sabine Kasimir-Bauer is an Associate Professor at the University Hospital of Essen, Germany, where she has held several positions since joining in 1993. She her received Ph.D. in 1993 from the Institute of Medical Microbiology and Immunology at the University of Bochum, Germany. Dr Kasimir-Bauer’s ongoing studies include expression profiling of CTCs including single cell analysis, compared with the expression on the primary tumor as well as the metastases to evaluate patients for targeted therapies. Besides CTC analysis in blood, the group focusses on circulating extracellular vesicles and circulating, cell-free DNA applying the use of unique molecular identifiers as well as next-generation sequencing.
Elaine Mardis, Columbus, Ohio, USA“I’m constantly inspired by cancer patients, especially our pediatric patients, and their families.”
Klaus Pantel, Hamburg, Germany“Each year almost 10 million people die of cancer worldwide and to contribute translational cancer research with the potential to reduce this number is my strongest motivation.”
Pithi Chanvorachote, Bangkok, Thailand“Understanding the defined molecular network and signaling of cancers can lead to discovering the ultimate drug targets that can then result in the best treatment.”
Seock-Ah Im, Seoul, Republic of Korea“We must build a more comprehensive network to facilitate academia, global pharmaceutical company and the biotechnology industry to run together.”
Sue Branford, Adelaide, Australia“We continue to work toward finding the reasons why some patients don’t have a successful outcome.”
You?What inspires you to do cancer research? We are happy to give these insights into the lives and work of cancer researchers. If you would like to share your story here, get in touch.